News - 30 Nov 2004
A new clinical study has shown that imatinib mesylate (Gleevec) has activity in AIDS-related Kaposi's sarcoma (KS). Imatinib inhibits important pathways that spur cancer growth, resulting in the...
News - 10 Oct 2018
Sarcoma patients show great openness to the use of complementary alternative medicines (CAMs) for supportive care, but they are poorly informed about safety issues and risk of interactions with...
News - 21 Aug 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment...
News - 17 Aug 2017
A popular theory in recent neuroscience proposes that slow development of the prefrontal cortex - and its weak connectivity with brain reward regions - explains teenagers' seemingly impulsive and...
News - 9 May 2017
If viewing your latest medical test results on your doctor'ss online portal leaves you scratching your head and wondering whether to start planning your 100th-birthday bash or begin writing your will,...
News - 5 Aug 2016
A group of Russian physicists, with the contribution from their Swiss colleagues, developed a way to use the therapeutic effect of heating or cooling the tissues due to the magnetocaloric effect.
News - 10 Jan 2014
Why do animals ranging from fruit flies to humans all need to sleep? After all, sleep disconnects them from their environment, puts them at risk and keeps them from seeking food or mates for large...
News - 27 Jan 2013
The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
News - 17 Nov 2008
Thanks to our ability to learn and to remember, we can perform tasks that other living things can not even dream of.
News - 17 Dec 2007
Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute...